Navigation Links
Combining liver cancer treatments doubles survival rates, UVA researchers find
Date:4/15/2008

Charlottesville, Va., April 15, 2008 By combining the use of stents and photodynamic therapy, also called SpyGlass, physicians at the University of Virginia have been able to significantly increase survival rates for patients suffering from advanced cholangiocarcinoma, cancer of the liver bile duct.

Most patients who develop this type of cancer cannot have surgery as it is diagnosed at such a late stage, so there was not much we could do except offer them palliative care, said University of Virginia Gastroenterologist Michel Kahaleh, M.D., lead investigator of the study. By combining therapies, we saw an improved survival rate from just more than 7 months to more than 16 months.

In the study, recently published in the March 2008 issue of Clinical Gastroenterology and Hepatology, 48 patients were treated with advanced cholangiocarcinoma over a five year period. Twenty-nine patients were treated with biliary stents, with the remaining 19 being treated with the stents and photodynamic therapy (PDT). The stents decompress the bile ducts, maintaining liver function. The combined therapy group received treatment every three months, at which time all stents were replaced.

The combined therapy group had survival rates of 16.2 months compared to the stent-only groups 7.4 months. Mortality rates in the group that received PDT was 0, 16, and 56 percent at three, six, and 12 months respectively. Mortality rates in the stent-only group were 28, 52, and 82 percent respectively. Kahaleh said the number of stent-replacement procedures and PDT sessions were the only factors which significantly impacted survival.

Photodynamic Therapy treatment uses a photosensitizing agent (porfimer sodium in this study) which is activated using light of a specific wavelength, which then kills the targeted cells. PDT has been used for more than a decade to destroy cancer cells and reduce tumor size.

Cancer of the liver bile ducts is the second most common
'/>"/>

Contact: David Foreman
daf4n@virginia.edu
434-924-2242
University of Virginia Health System
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Combining Internet With Office Visits Cut Heart Attack Risks
2. NeoStrata Clinical Findings Reveal Benefits of Combining Glycolic Acid Peels and Targeted Home Care With Microdermabrasion for Optimized Treatment of Photodamaged Skin
3. Combining Medications Often Best Strategy to Battle Rheumatoid Arthritis
4. In blood vessel stents, innovative materials allow better control, delivery of gene therapy
5. New Treatments Help Fight Liver, Colon Cancer
6. Health Care Work Force Too Small, Unprepared for Aging Baby Boomers; Higher Pay, More Training, and Changes in Care Delivery Needed to Avert Crisis
7. Penn researchers find targeted therapy combination overcomes treatment resistance in liver cancer
8. New technique in treating patients with liver cancer proves effective
9. Mayo Clinic identifies treatment target for liver cancer recurrence and survival
10. New York Cigarette Tax Increase Delivers Victory for Kids and Taxpayers
11. Two Liver Cancer Treatments Better Than One
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... -- Arriving home safe and sound is one of the ... sure that costumes and goody bags have reflective strips that ... medicine doctor at Meadowlands Hospital Medical Center in Secaucus, N.J. ... should be flame-resistant, Davis said. He offers these others ... it on a small area of skin first to ensure ...
(Date:10/25/2014)... October 25, 2014 The ... which verifies IT-accessibility for disabled users by disabled ... logo to Mackin Educational Resources of Burnsville, ... management system and to the Minnesota Alliance for ... "Own Best Medicine" website. Both organizations ...
(Date:10/25/2014)... York, New York (PRWEB) October 25, 2014 ... transvaginal mesh lawsuits ( http://www.vaginalmeshlawsuit2015.com/ ) filed ... litigation underway in U.S. District Court, Southern District ... for Summary Judgment on Punitive Damages in a ... plaintiffs. In a ruling issued on October 21st, ...
(Date:10/25/2014)... HealthDay Reporter FRIDAY, Oct. 24, 2014 (HealthDay ... herpes simplex -- might increase the risk of Alzheimer,s disease, ... a carrier of certain antibodies to the virus can double ... "The identification of a treatable cause [herpes simplex] of the ... Dr. Hugo Lovheim, an associate professor in the department of ...
(Date:10/25/2014)... Current osteoporosis screening guidelines and tools fail to ... osteoporosis-related fractures, a new study says. "If ... that help us accurately predict who will suffer ... these at-risk people for preventive measures," study author ... division of general internal medicine and health services ...
Breaking Medicine News(10 mins):Health News:Tips for Safe Trick-or-Treating 2Health News:IT-Accessibility Award Granted to Education and Health Care for Section 508/WCAG 2Health News:IT-Accessibility Award Granted to Education and Health Care for Section 508/WCAG 3Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 3Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 4Health News:Studies Link Cold Sore Virus to Alzheimer's Risk 2Health News:Studies Link Cold Sore Virus to Alzheimer's Risk 3Health News:Osteoporosis Screening Guidelines May Miss Younger Women at Risk 2
... , , , , ... on senior living communities, 43-year-old Steve Gurney, the founder and publisher ... a temporary resident of The Residences of Thomas Circle, a downtown ... on his blog www.everyoneisaging.com. , , During the ...
... , , WASHINGTON, Aug. 11 ... ZOOM-100DC brain electrical activity data collection system, has been cleared ... section 510(k) of the FD&C Act. The ZOOM-100DC is an ... and displaying EEG waveforms and providing conventional EEG measures displayed ...
... , , WILMINGTON, Mass., ... dermatology company that is developing and marketing Levulan((R)) Photodynamic Therapy (PDT) ... today its corporate highlights and financial results for the second quarter ... http://www.newscom.com/cgi-bin/prnh/20090810/D C 59366LOGO ) ...
... OF PRUSSIA, Pa., Aug. 11 At the CBI 3rd Annual ... announced the commercial release of CompleteSpend(TM) V2.5. CompleteSpend is the ... compliance needs. , , (Logo: ... , , Myriad state and pending federal laws ...
... Awarded $100,000 for Enhancing Health Care Delivery , , ... , , WASHINGTON , Aug. 11 Dr. ... his exceptional work to enhance health care delivery for hundreds of low income ... prize, named for Joseph H. Kanter, a pioneering advocate for electronic medical records, ...
... , , , , ... 2009 , PADRES Contra El Cancer (PADRES), a non-profit organization committed to improving ... the Spike for HOPE! Celebrity Volleyball match as part of the ... PRESENTED BY VIRGIN AMERICA . , , (Photo: http://www.newscom.com/cgi-bin/prnh/20090811/LA59829 ...
Cached Medicine News:Health News:Middle-Aged Senior Care Advocate to Move Into D.C. Retirement Community 2Health News:BrainScope(TM) Receives FDA Clearance for Portable EEG Device 2Health News:BrainScope(TM) Receives FDA Clearance for Portable EEG Device 3Health News:DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 2Health News:DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 3Health News:DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 4Health News:DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 5Health News:DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 6Health News:DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 7Health News:DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 8Health News:DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 9Health News:DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 10Health News:DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 11Health News:DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 12Health News:DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 13Health News:Health Market Science Announces Commercial Release of CompleteSpend V2.5 2Health News:Health Market Science Announces Commercial Release of CompleteSpend V2.5 3Health News:Dr. James O'Connell Named J.H. Kanter Prize Laureate 2Health News:Dr. James O'Connell Named J.H. Kanter Prize Laureate 3Health News:Kevin Nealon, Jordan Farmar, Walter Perez, Cristian de la Fuente and Other Celebrities Participated in Beach Volleyball Match for Children With Cancer 2Health News:Kevin Nealon, Jordan Farmar, Walter Perez, Cristian de la Fuente and Other Celebrities Participated in Beach Volleyball Match for Children With Cancer 3
(Date:10/25/2014)... Burzynski Research Institute, Inc. (BRI) announced today that the ... company permission to conduct an open-label study of Antineoplastons ... age with a diffuse intrinsic brainstem glioma (DIPG). Study ... groups based on their age and whether or not ... study endpoint is a decrease in the size of ...
(Date:10/22/2014)...  Rescheduling of hydrocodone combination products (HCPs) will ... according to a new primary market research study ... research and consultation exclusively in the area of ... In August, the DEA ... from Schedule III to Schedule II status. This ...
(Date:10/22/2014)... BASKING RIDGE, N.J. , Oct. 22, 2014 ... (RMANJ), a world-renowned leader in the field ... more rapid approach to embryonic screening. The research ... American Society for Reproductive Medicine (ASRM) meeting in ... chromosome screening (CCS) and single gene defect (SGD) ...
Breaking Medicine Technology:Burzynski Research Institute, Inc. Announces FDA Permission to Launch a New Clinical Trial in Diffuse Intrinsic Brainstem Glioma 2Hydrocodone: Rescheduled, Repositioned & Reinvented 2Hydrocodone: Rescheduled, Repositioned & Reinvented 3New IVF Research Highlights Improved Genetic Screening Approach To Help Parents Have Healthier Babies 2New IVF Research Highlights Improved Genetic Screening Approach To Help Parents Have Healthier Babies 3
... 26, 2012  Richard Wolf Medical Instruments Corporation celebrates ... minimally invasive solutions that spare patients the costs ... (Logo:  http://photos.prnewswire.com/prnh/20120426/CG95191LOGO ) ... allowing doctors to visualize and access elusive sites ...
... April 26, 2012 - The Consumer Healthcare Products ... for signing into law House Bill 363, legislation ... implementing a drug offender registry, stricter penalties for ... stop-sale technology.  HB 363 and its companion legislation ...
Cached Medicine Technology:Richard Wolf Medical Instruments Corporation: 40 Years of Innovation 2
... 8F Percutaneous Vascular Surgical (PVS) System consists of ... Perclose Knot Pusher. The Prostar XL 8F PVS ... two pairs of sutured needles as well as ... precisely control the needles during deployment. the Perclose ...
... The new solid-state IRIS Medical IQ ... the treatment of retinal disorders and ... represents its latest technological innovation and ... Minimum Intensity Photocoagulation (MIP) procedures in ...
... The AIA-360 is a sophisticated Aumated Immunoassay Analyzer ... analyzer has a footprint of 16 X 16 ... Its compact design is ideal for physician ... testing, such as cardiac panels, as well as ...
... Solitaire represents the latest in green laser ... for use in both the operating room ... preference testing and the most experienced ophthalmic ... is the premium 532nm photocoagulator - unique ...
Medicine Products: